Amgen Knocks Roche In Early Round Of EPO Court Fight
Federal judge rules that Roche’s EPO product Mircera infringes a key Amgen patent, although trial is still set for Sept. 4.
Federal judge rules that Roche’s EPO product Mircera infringes a key Amgen patent, although trial is still set for Sept. 4.